Abbott Laboratories: Device Recall
Recall #Z-2681-2024 · 06/14/2024
Recall Details
- Recall Number
- Z-2681-2024
- Classification
- Class II
- Product Type
- Device
- Recalling Firm
- Abbott Laboratories
- Status
- Ongoing
- Date Initiated
- 06/14/2024
- Location
- Santa Clara, CA, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 816
Reason for Recall
1)If Complete Blood Count with differential and reticulocyte(CBC+Diff+Retic) sample is run, then immediately following on same rack CBC+Diff sample is run, then falsely low red blood cell count may occur, generating falsely high Mean Cell Hemoglobin(MCH)/MCHC and falsely low hematocrit results. 2)Cell events may be incorrectly counted as basophil(BASO), resulting in increased BASO and %BASO counts
Product Description
Alinity hq Analyzer, REF: 09P68-01
Distribution Pattern
Worldwide - US Nationwide distribution in the states of NY, OK, NC and the countries of ALBANIA, ARGENTINA, AUSTRALIA, BANGLADESH, BELGIUM, BOSNIA AND HERZEGOVINA, Botswana, BRAZIL, BULGARIA, CANADA, CAYMAN ISLANDS, CHILE, COLOMBIA, CROATIA, CZECH REPUBLIC, DENMARK, EGYPT, FRANCE, GERMANY, GREECE, HONDURAS, HONG KONG, HUNGARY, INDIA, INDONESIA, ITALY, JAMAICA, JAPAN, JORDAN, KUWAIT, LEBANON, LITHUANIA, MALAYSIA, MALDIVES, MEXICO, NETHERLANDS, NORWAY, OMAN, PAKISTAN, PANAMA, PHILIPPINES, POLAND, PORTUGAL, QATAR, ROMANIA, SAUDI ARABIA, SERBIA, SLOVENIA, SOUTH AFRICA, SOUTH KOREA, SPAIN, SWITZERLAND, THAILAND, TRINIDAD & TOBAGO, TURKEY, UAE, UK, URUGUAY, VIETNAM.
Other Recalls by Abbott Laboratories
- Class II: Risk 11/13/2025
- Class II: Risk 09/18/2025
- Class II: Risk 03/18/2025
- Class II: Risk 03/18/2025
- Class II: Risk 03/18/2025